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Abstract
Background: Metabolic Syndrome is associated with increased risk for type 2 diabetes and cardiovascular diseases.
However, different diagnostic criteria have been recommended by different expert groups. In Malaysia, there is a
lack of research comparing these different diagnostic criteria. Therefore, it is our aim to study the concordance
between the IDF and the modified NCEP ATP III definitions of Metabolic Syndrome among a Malay cohort in Kuala
Lumpur; and to demonstrate if all participants have the same cardiometabolic risks.
Methods: This was an analytical cross sectional study. Ethics approval was obtained and informed consent was
given by all participants. Anthropometric measurements, blood pressure, fasting blood glucose and lipid profile
were taken following standard protocols.
Results: Metabolic Syndrome was diagnosed in 41.4% and 38.2% participants using the modified NCEP and IDF
criteria respectively. Among those diagnosed with Metabolic Syndrome by modified NCEP, 7.6% were missed by
the IDF criteria. Participants diagnosed by the modified NCEP criteria had lower BMI and waist circumference but
had higher cardiometabolic risks than those diagnosed with both criteria. Their blood pressure, glucose, total
cholesterol and triglyceride were more adverse than the IDF group. This demonstrated that central obesity may
not be a prerequisite for the development of increased cardiometabolic risks within this Malay cohort.
Conclusion: Metabolic syndrome is common in this Malay cohort regardless of the criterion used. The modified
NCEP ATP III criteria may be more suitable in diagnosis of metabolic syndrome for this Malay cohort.
Background
Metabolic Syndrome has been demonstrated as a com-
mon precursor to the development of type 2 diabetes
and cardiovascular disease (CVD)[1] as well as a risk
factor for all cause mortality[2]. Individuals with Meta-
bolic Syndrome are associated with approximately five
and two-fold increased risk for type 2 diabetes and CVD
respectively[1]. Metabolic syndrome has also been linked
with obesity and a sedentary lifestyle, both of which are
modifiable [3]. More effort should be given to promot-
ing a healthy lifestyle with increased physical activity
and reduced obesity [1,4] . Individuals with metabolic
syndrome should be identified early so that their cardio-
vascular risk factors can be reduced[5].
Although there is general consensus that obesity and
metabolic syndrome requires greater attention, there is
disagreement over the diagnostic criteria of metabolic
syndrome. Different criteria used for diagnosing Meta-
bolic Syndrome provide differing results. Expert groups
from the International Diabetes Federation (IDF),
National Cholesterol Education Program Adult Treat-
ment Panel III (NCEP ATP III), World Health Organisa-
tion (WHO) etc have different diagnostic criteria [1,6,7].
In Malaysia there is a paucity of studies comparing the
different diagnostic criteria with the modified waist cir-
cumference cut-off values which are ethnic and gender
specific as recommended by IDF and the modified NCEP
ATP III criteria. We therefore set out to study the con-
cordance between these two definitions of Metabolic syn-
drome among a Malay cohort in Kuala Lumpur; and to
demonstrate if participants identified by the modified
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Methods
Study population
This was an analytical cross-sectional study. The study
population was the Malay employees from a health
screening program of a public university in Kuala Lum-
pur. All eligible Malay employees were invited to take
part in the study. A total of 1494 Malay employees par-
ticipated in the study, giving a response rate of 85%. All
participants were aged 35 years and above as this
screening program only included staff of this age range.
Approval was obtained (reference number MEC 782.18)
from the Medical Ethics Committee of the medical cen-
tre. This committee is responsible for ethical issues in
all research projects involving humans conducted by
Medical Faculty staff of the university. Approval was
also obtained from the management of the university.
Written informed consent was given by all participants.
Data Collection
Data was collected over two years (2008-2009) in the
university campus. Measurements included anthropo-
metric measurements (weight, height, waist and hip cir-
cumference); systolic and diastolic blood pressure,
fasting blood glucose and fasting lipid profile were also
taken. Weight and height were measured using cali-
brated digital weighing scales and stadiometers respec-
tively. The waist and hip circumferences were measured
with circumference measurement tape. The waist was
defined as the point midway between the iliac crest and
the costal margin (lower rib); while the hip circumfer-
ence was defined as being the widest circumference over
the buttocks and below the iliac crest [8,9]. All measure-
ments were conducted by trained staff and quality
checks were conducted regularly.
Blood pressure was measured using a digital automatic
blood pressure monitor (Omron HEM - 907 model)
while lipid profile was analyzed using the Dimension®
clinical chemistry system which was an in-vitro diagnos-
tic test. All biochemical analysis was conducted by the
Clinical Diagnostic Laboratory of the medical centre
from the same university. Body Mass Index (BMI) was
derived following the formula of weight in kg/height
2 in
meters. We used a self-reported diagnosis of diabetes and
hypertension in the study.
Definition of Metabolic Syndrome
Metabolic syndrome was defined following the criteria
provided by the modified NCEP ATP III and IDF groups.
According to the modified NCEP criteria [1], the presence
of any three of the following five factors is required for a
diagnosis of Metabolic Syndrome: abdominal obesity,
hypertriglyceridaemia (triglycerides ≥1.7 mmol/L); low
HDL cholesterol (HDL cholesterol ≤1.03 mmol/L for men
and ≤1.29 mmol/L for women); elevated blood pressure
(systolic blood pressure ≥130 mmHg and/or diastolic
blood pressure ≥85 mmHg or current use of antihyperten-
sive drugs); impaired fasting glucose (fasting plasma glu-
cose ≥5.6 mmol/L). The modified NCEP ATP III criteria
suggested the cut-off points of waist circumference should
be ethnic specific where individuals of Asian origin should
use the cut-off of 90 cm in men and 80 cm in women. For
NCEP criteria, abdominal obesity is a component of the
syndrome but not a prerequisite for its diagnosis. The
IDF’s diagnosis of Metabolic Syndrome places emphasis
on abdominal obesity as a required factor [10] plus any
two of the other four criteria which are essentially identical
to those provided by NCEP ATP III. The IDF criterion
uses ethnic-specific waist circumference cut-off points as a
requirement for diagnosis. Similar to the modified NCEP
ATP III criteria, IDF recommends cut-off levels of 90 cm
in men and 80 cm in women for central obesity among
Asians. For both criteria, we used the recommended cut-
o f ff o rA s i a n s( 9 0c mi nm e na n d8 0c mi nw o m e n )a s
there are no national cut-off values specific for Malaysia.
Data Analysis
Data was entered and analysed using SPSS for Windows
version 16.0. Categorical variables were presented as fre-
quency and percentages while quantitative variables
were presented as mean with 95% confidence interval
where appropriate. Kappa statistics was used to measure
agreement between the two criteria. Independent t test
was used to compare the cardiometabolic risks among
gender.
Results
A total of 1494 Malay employees participated in the
study with 697 (46.7%) males. Half of them were in
their fifties (Table 1). About 5.5% of them were diag-
nosed with type II diabetes mellitus while 12.2% were
hypertensive.
Metabolic Syndrome was diagnosed in 618 (41.4%) and
571 (38.2%) participants using the modified NCEP and
I D Fc r i t e r i ar e s p e c t i v e l y( T a b l e1 ) .T h ep r e v a l e n c eo f
Metabolic Syndrome among males and females were
54.7% and 45.3% for the modified NCEP criteria; and
52.9% and 47.1% for IDF criteria respectively. There were
47 (36 males and 11 females) or 7.6% of all participants
who were diagnosed by the modified NCEP criteria but
missed by the IDF criteria. Those participants missed by
the IDF criteria were mainly males (76.6%). There were
no participants who were diagnosed by IDF but missed
by the modified NCEP criteria. Among those diagnosed
to have Metabolic Syndrome, 92% of participants were
identified equally by both criteria. The prevalence of
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49 years, followed by those aged 50-59 years. The preva-
lence among those aged 60 years and older was the low-
est among all age groups (Table 1). About 11% of the
participants diagnosed with Metabolic Syndrome were
diabetics while 18% were hypertensive. There was no sig-
nificant difference in the prevalence of diabetes or hyper-
tension observed in those diagnosed as having Metabolic
Syndrome by either IDF or modified NCEP criteria. The
agreement of these two criteria as shown by the Kappa
statistics was 0.93.
Table 2 compares cardio-metabolic risk factors of
Metabolic Syndrome diagnosed by the IDF and modified
NCEP criteria. Participants who were not diagnosed by
both criteria were significantly younger than the other
two groups (either diagnosed by the modified NCEP
only or diagnosed by both the modified NCEP and IDF
criteria). They also had the lowest levels of systolic and
diastolic blood pressure, glucose and lipid profiles. BMI
and waist circumferences reflecting overall obesity and
central obesity were significantly lower among those
diagnosed by the modified NCEP criteria only. Systolic
and diastolic blood pressure, total cholesterol, LDL-cho-
lesterol, glucose and triglyceride were found to be high-
est while HDL-cholesterol was lowest among the
modified NCEP group.
Stratified analysis of the above cardio-metabolic risk
factors by sex was also conducted to explore if there
was any gender difference observed in all sub-groups
(Table 3). In the modified NCEP group, females were
found to have more adverse levels of fasting blood glu-
cose, systolic and diastolic blood pressure; while the
males were found to have higher levels of total choles-
terol, triglyceride and LDL-cholesterol. Mean BMI was
also higher in females. However, all these observed dif-
ferences were not statistically significant (p > 0.05). The
only significant gender differences observed were waist
circumference (higher in males) and HDL-cholesterol
level (higher in females). In the group diagnosed by
both modified NCEP and IDF criteria, females were sig-
nificantly (p < 0.01) more obese and had higher HDL-
cholesterol while males had larger waist circumference
(p < 0.001) and higher triglyceride level (p < 0.001).
Although there were no significant gender difference
Table 1 Prevalence of Metabolic Syndrome and baseline characteristics by IDF or modified NCEP criteria
Total population
(n = 1494)
IDF
(n = 571)
Modified NCEP
(n = 618)
Prevalence (%) 38.2 41.4
Gender: Male 697 (46.7) 302 (52.9) 338 (54.7)
Female 797 (53.3) 269 (47.1) 280 (45.3)
Age group: Less than 40 years 191 (12.8) 61 (10.7) 61(9.9)
40 - 49 years 774 (51.8) 270 (47.3) 300 (48.5)
50 - 59 years 493 (33.0) 227 (39.8) 243 (39.3)
60 years and above 36 (2.4) 13 (2.3) 14 (2.3)
Diabetes mellitus 82(5.5) 61 (10.7) 69 (11.2)
Hypertension 183 (12.2) 103 (18.0) 109 (17.6)
Table 2 Comparison of cardiometabolic risk factors of metabolic syndrome by modified NCEP and IDF criteria
NCEP only
Mean (95% CI)
(n = 47)
Both
(NCEP and IDF)
Mean (95% CI)
(n = 571)
Neither
(NCEP or IDF)
Mean (95% CI)
(n = 876)
Age (years) 49.1 (47.7, 50.4) 48.3 (47.8, 48.9) 47.0 (46.6, 47.4)
BMI 24.2 (23.6, 24.9) 29.5 (29.2, 29.9) 25.7 (25.4, 25.9)
Waist (cm) 82.8 (81.3, 84.3) 95.6 (94.8, 96.3) 84.6 (83.9, 85.3)
Systolic blood pressure (mmHg) 142.2 (137.3, 146.9) 139.4 (137.9, 140.9) 125.4 (124.3, 126.6)
Diastolic blood pressure (mmHg) 87.9 (85.1, 90.8) 86.7 (85.8, 87.6) 78.1 (77.4, 78.8)
Glucose (mmol/l) 8.4 (7.0, 9.8) 6.6 (6.4, 6.9) 4.9 (4.9, 5.2)
Total cholesterol (mmol/l) 5.9 (5.6, 6.3) 5.6 (5.6, 5.7) 5.5 (5.5, 5.6)
Triglyceride (mmol/l) 2.7 (2.3, 3.1) 2.1 (1.9, 2.2) 1.1 (1.1, 1.2)
HDL-cholesterol (mmol/l) 1.0 (0.9, 1.1) 1.1 (1.0, 1.1) 1.4(1.3, 1.4)
LDL- cholesterol (mmol/l) 3.7 (3.4, 4.0) 3.6 (3.5, 3.7) 3.6 (3.5, 3.7)
CI: Confidence Interval
BMI: Body Mass Index, HDL: High Density Lipoprotein, LDL:Low Density Lipoprotein
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blood pressure and total cholesterol levels were higher
among males in this group. On the other hand, males
who were not diagnosed with either criterion had signif-
icantly higher mean levels of cardiometabolic risk fac-
tors than their counterparts.
Discussion
The overall prevalence of Metabolic Syndrome in this
cohort was high regardless of any criteria used. This
cohort’s older age and its Malay ethnicity may partly
explain this high prevalence. Preliminary results derived
from a rural area with a predominantly Malay popula-
tion in Malaysia suggested that metabolic syndrome, as
defined by the IDF criteria, affected an estimated 36.5%
and 50.5% of adult males and females respectively [11],
findings which were quite similar to ours. However, our
results show a higher prevalence than Malays from Sin-
gapore within the same age groups [12].
We observe that the prevalence of Metabolic Syndrome
increased with age but was reduced in the oldest age
group. This contradicts results shown elsewhere [12,13].
The unexpected low prevalence among the oldest age
group can either be attributed to the “healthy worker
effect” or merely be a chance finding. More males were
diagnosed with Metabolic Syndrome compared to
females using either criterion as reported in a study
among Singapore Malays [12]. However, a survey of rural
Malays in Malaysia [11] demonstrated a higher preva-
lence of Metabolic Syndrome among females (50.5%)
compared to males (36.5%). Working status may be the
reason for this difference. All our female participants
Table 3 Comparison of cardiometabolic risk factors by sex using modified NCEP and IDF criteria
NCEP only
(n = 47)
(Male = 36, Female = 11)
Both
(NCEP and IDF)
(n = 571)
(Male = 295, Female = 266)
Neither
(NCEP or IDF)
(n = 876)
(Male = 517, female = 359)
Mean ± s.d. p Mean ± s.d. p Mean ± s.d. p
Age (years) Male 49.1 ± 4.4 0.98 48.7 ± 6.6 0.17 47.6 ± 6.7 0.02
Female 49.1 ± 5.5 48.0 ± 5.6 46.6 ± 5.9
BMI Male 24.0 ± 2.3 0.20 28.5 ± 3.4 <0.001 25.4 ± 4.1 0.03
Female 25.0 ± 2.0 30.8 ± 5.0 25.9 ± 4.4
Waist (cm) Male 84.9 ± 3.5 <0.001 97.6 ± 7.9 <0.001 88.5 ± 10.9 <0.001
Female 75.9 ± 2.6 93.3 ± 9.8 81.9 ± 10.1
Systolic blood pressure (mmHg) Male 140.4 ± 14.6 0.19 139.9 ± 17.0 0.46 129.3 ± 16.7 <0.001
Female 147.9 ± 21.3 138.8 ± 19.5 122.8 ± 16.3
Diastolic blood pressure (mmHg) Male 87.0 ± 8.4 0.35 86.6 ± 10.6 0.85 79.8 ± 10.4 <0.001
Female 91.0 ± 12.9 86.8 ± 11.3 76.9 ± 10.6
Glucose (mmol/l) Male 8.1 ± 4.9 0.34 6.6 ± 2.8 0.96 5.1 ± 1.0 0.01
Female 9.6 ± 4.6 6.6 ± 2.9 4.9 ± 0.8
Total cholesterol (mmol/l) Male 6.1 ± 1.2 0.20 5.7 ± 1.1 0.15 5.6 ± 0.9 0.02
Female 5.6 ± 0.8 5.6 ± 1.1 5.5 ± 1.2
Triglyceride (mmol/l) Male 2.9 ± 1.4 0.07 2.3 ± 1.1 <0.001 1.4 ± 0.7 <0.001
Female 2.1 ± 0.8 1.8 ± 1.2 0.9 ± 0.4
HDL-cholesterol (mmol/l) Male 1.0 ± 0.1 <0.001 1.1 ± 0.2 <0.001 1.3 ± 0.2 <0.001
Female 1.2 ± 0.2 1.2 ± 0.2 1.5 ± 0.3
LDL- cholesterol (mmol/l) Male 3.9 ± 1.1 0.12 3.6 ± 1.0 0.51 3.8 ± 0.9 <0.001
Female 3.2 ± 1.1 3.6 ± 0.9 3.5 ± 0. 8
CI: Confidence Interval; s.d: standard deviation
BMI: Body Mass Index, HDL: High Density Lipoprotein, LDL:Low Density Lipoprotein
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areas were housewives. In the latest Malaysian National
Health & Morbidity Survey III (NHMS III) in 2006, a
greater proportion of housewives were found to be obese
compared to other occupation categories [14]. A lack of
gainful employment, which may be associated with lower
education and lower self-esteem, may in part explain this
difference between our sample and that of rural Malay
women.
Our results showed both the modified NCEP ATP III
and IDF criteria similarly diagnosed 92.4% of participants
as having Metabolic Syndrome. The Kappa statistics also
suggested high agreement between these two criteria after
correction for agreement by chance. Despite the above
similarities and agreement in the diagnosis of Metabolic
Syndrome, these two criteria provided different prevalence
estimates and identify different individuals.
Similar to our findings, Lee et al and Xavier et al found
higher prevalence of Metabolic Syndrome among Singa-
poreans and Japanese respectively using modified NCEP
criteria compared to IDF criteria [13,15]. In another
study among the Koreans, the IDF criteria too failed to
identify 44.9% of men and 16.6% of women as having
Metabolic Syndrome according to the modified NCEP
criteria [16]. Those missed by the IDF criteria were pre-
dominantly males. This group of participants (identified
by NCEP criteria alone) had lower BMI and waist cir-
cumference but at a higher cardio-metabolic risk than
those diagnosed with both criteria. Their blood pressure,
glucose, total cholesterol and triglyceride levels were
more adverse than the other two groups. Similar results
were found in other studies among Asians [16,17]. Due
to the small sample size in the modified NCEP group,
there was inadequate evidence to show if there was any
gender difference in most of the cardiometabolic risk fac-
tors. The only observed difference was higher HDL-cho-
lesterol levels among females and larger waist
circumference among males which most probably may
be due to gender specific physiological difference. On the
other hand, males who were not diagnosed with either
criterion had significantly higher mean levels of cardio-
metabolic risk factors than females. However, most of
these risk factors were within normal ranges except for
total cholesterol and LDL-cholesterol. This group of par-
ticipants should be targeted for health education and
promotion programs in the prevention of Metabolic
Syndrome.
The proportions of participants with diabetes and
hypertension were not significantly different in the modi-
fied NCEP group or group diagnosed by both criteria.
This demonstrated that the adverse levels as observed in
the modified NCEP group were not due to higher pro-
portions of participants with diabetes and hypertension.
We are of the opinion that central obesity may not be the
prerequisite for the development of increased cardio-
metabolic risks as reported elsewhere [13]. According to
Lee at al [13], the definition of Metabolic Syndrome
should have central obesity as an “optional” rather than
“essential” criterion as this would identify more high risk
individuals among the Asians. Similar recommendations
were given in the recent Joint Scientific Statement in
“Harmonizing the Metabolic Syndrome” [18] by the var-
ious expert groups. Their consensus was that there
should not be an obligatory component. Any three
abnormal findings out of five should suffice to diagnose a
person as having Metabolic Syndrome. A single cut-off
point would be used for all components except waist cir-
cumference where the interim national or regional cut-
off points can be used. Within this Malay cohort, adverse
cardio-metabolic risks were observed in those with lower
BMI or waist circumference. Zahel et al [19] recom-
mended waist circumference cut off value of 83 cm for
both males and females to define overweight or obesity
among adults in Malaysia. This recommended cut off
value for males is lower than 90 cm while for females is
higher than 80 cm as recommended by NCEP ATP III
[1] and IDF [10]. We think further studies are required
to determine the suitability of 90 cm and 80 cm as the
optimal cut- off levels for central obesity in Malays.
As this is a cross-sectional study, we cannot examine
which criterion for diagnosing Metabolic Syndrome has
better predictive power in diagnosing diabetes, CVD and
premature death. Follow-up studies are needed to exam-
ine the significance of Metabolic Syndrome following all
criteria for the assessment of risk for diabetes and/or
CVD. As this study population is from a public univer-
sity, the findings may not be easily generalised to the
whole Malay population of the country. However, it
c a n n o tb ed e n i e dt h a tt h i ss t u d yi so n eo ft h ef e wt h a t
compared the two different definitions of Metabolic
Syndrome among a reasonably large sample in Malaysia.
This will provide a basis for future and larger scale stu-
dies on this topic in Malaysia.
Conclusion
In conclusion, Metabolic Syndrome is common in this
Malay cohort in Kuala Lumpur regardless of the criteria
used. The modified NCEP ATP III criteria may be more
suitable in diagnosing Metabolic Syndrome in this
Malay cohort. An effective intervention program should
also be planned for this cohort as the complications of
Metabolic Syndrome including diabetes and CVD, will
become epidemic in the near future.
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